Live MD Anderson Cancer Center News with Latest Updates

Live MD Anderson Cancer Center news and developments with the latest updates. Check out current MD Anderson Cancer Center news stories and find out what happened, what is going on with MD Anderson Cancer Center. Recent news updates about MD Anderson Cancer Center
Colon cancer surgery performed by highly skilled surgeons improves long-term survival for patients
Chan Zuckerberg Initiative supports diversity in Human Cell Atlas project
MD Anderson’s fifth annual Boot Walk to End Cancer goes virtual
Focus Fund and MD Anderson launch investment fund to support promising investigational cancer therapies
MD Anderson, UT Austin Announce First Collaborative Projects in United Fight to End Cancer
UT Austin, MD Anderson Announce First Collaborative Projects in United Fight to End Cancer
MD Anderson and Allogene Therapeutics announce strategic collaboration to accelerate advancement of allogeneic CAR
MD Anderson earns fifth Magnet designation for nursing excellence
Dual checkpoint blockade promising as pre-surgical approach for certain patients with localized bladder cancer
Study identifies characteristics of infused CAR T cells associated with efficacy and toxicity
MD Anderson and Taiho Pharmaceutical announce collaboration to accelerate development of novel therapies for brain
KRAS inhibitor sotorasib appears safe, achieves durable clinical benefit in early trial
New study from MD Anderson and BridgeBio’s Navire Pharma shows SHP2 inhibition overcomes multiple
Combination immunotherapy benefits subset of patients with advanced prostate cancer
MD Anderson and Astex Pharmaceuticals announce strategic collaboration to accelerate clinical evaluation
Three research teams earn Dunn Awards
MD Anderson and Xencor enter strategic collaboration to advance investigational XmAb drug candidates
Lung cancer trial of RET inhibitor selpercatinib achieves durable responses
Novel PROTAC enhances its intracellular accumulation and protein knockdown
Researchers Call for International Collaboration on Parathyroid Cancer
Protein ‘chameleon’ colors long-term memory
$24 million in CPRIT funding awarded to MD Anderson and related research
Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations
Screenings for cardiac dysfunction among childhood cancer survivors can be more precisely tailored
Study shows frequently used serology test may not detect antibodies that could confirm protection against
Combination therapy significantly improves survival outcomes for patients with acute myeloid leukemia
Researchers enrolling patients for study to train AI in assisting breast cancer surgery
Implementation of social distancing policies correlates with significant reduction
New Machine Learning Method Allows Hospitals to Share Patient Data Privately
MD Anderson honored to rank as nation’s best hospital for cancer care
ACS launches Cancer Surgery Standards Program to improve quality of surgical cancer care
MD Anderson and Sanofi announce strategic collaboration to accelerate oncology research and development
MD Anderson and UT Austin Create Unique Data-Driven Collaboration to Eliminate Cancer Using Novel Mathematical
This Enigmatic Protein Sculpts DNA to Repair Harmful Damage
New Ranking Puts UT Austin Among Top Universities in World
Study shows sedentary behavior independently predicts cancer mortality
Combination biomarker predicts response to immune checkpoint therapy
MD Anderson and Philips collaborate to facilitate personalized oncology treatments and clinical trial matching
Drug with new approach on impeding DNA repair shows promise in first clinical trial
Inherited mutation increases risk of prostate cancer in men of African descent
MD Anderson and Rakuten Medical announce strategic alliance to advance Illuminox platform for cancer treatments
Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity
Novel targeted drug induced positive response for patients with von Hippel-Lindau disease-associated kidney cancer
MD Anderson and Innovent Biologics announce a strategic collaboration to develop anti-PD-1 therapy TYVYT
COVID-19 research funds back six new initiatives
Testing tuberculosis vaccine for COVID-19
Roots of language
Study finds no overall survival benefit, but improved quality of life with talazoparib